Urology Clinical Trials Update: Week 24, 2026

Published June 12, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma

This Phase 2 trial from Yale University is exploring whether adding surgery or other local treatments after initial systemic therapy can help control urothelial carcinoma that has spread only to a few sites. For patients with locally advanced or limited metastatic disease who respond well to initial treatment, this approach might improve outcomes by targeting residual cancer. The study is ongoing in the United States, and results are expected after at least 12 months of follow-up.

Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions

Researchers at Peking University First Hospital are testing different ways to perform prostate biopsies in men with prostate cancer who have several suspicious areas seen on MRI scans. The goal is to find the biopsy method that best identifies important cancers, helping doctors make more informed treatment decisions. This large study is recruiting participants in China, with over 570 men expected to join.

Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer

Also led by Peking University First Hospital, this trial compares various prostate biopsy techniques to improve the accuracy of prostate cancer diagnosis. By refining biopsy methods, the study aims to reduce unnecessary procedures and better detect cancers that need treatment. The trial is recruiting about 640 participants in China and is testing new biopsy combinations around suspicious areas.

Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer

This Austrian study is examining whether using a combination of high-frequency micro-ultrasound with MRI-targeted biopsies can improve prostate cancer detection. If successful, this method could help find significant cancers more accurately while avoiding overdiagnosis of less serious cases. The trial plans to enroll 400 men suspected of having prostate cancer.

Effectiveness of Chinese Herbal Medicine for Older Adults With Urinary Incontinence

A trial in Canada is testing whether Chinese herbal medicine can help older adults manage urinary incontinence symptoms. This is a placebo-controlled study aiming to find new treatment options that might have fewer side effects than current medications. About 150 participants will take part, and the results could offer a different approach to improving quality of life for those affected.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.